PAVM · NASDAQ
PAVmed (PAVM) Stock Price & Fundamentals
PAVmed (PAVM) closed at $852.11 on Oct 9, 2026, down 1.40% from the previous close of $864.23.
Share price, past year
1Y +38.60%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $852.11 |
| Sep 30, 2026 | $867.42 |
| Aug 31, 2026 | $851.95 |
| Jul 31, 2026 | $793.26 |
| Jun 30, 2026 | $791.52 |
| May 29, 2026 | $752.21 |
| Apr 30, 2026 | $729.15 |
| Mar 31, 2026 | $696.58 |
| Feb 27, 2026 | $679.17 |
| Jan 30, 2026 | $680.86 |
| Dec 31, 2025 | $710.37 |
| Nov 28, 2025 | $681.58 |
| Oct 31, 2025 | $619.77 |
Key statistics
- Market cap
- $5.34B
- P/E (TTM)
- 803.9
- EPS (TTM)
- $1.06
- Revenue (TTM)
- $112.00K
- Net income (TTM)
- −$12.09M
- Shares outstanding
- 6.3M
- Dividend yield
- —
- 52-week range
- $597.76 – $887.69
PAVmed's market cap is $5.34B, based on a share price of $852.11 and 6.3M shares outstanding as of Jun 30, 2026.
Financials
PAVmed reported revenue of $71.00K for fiscal 2025, down 97.63% from fiscal 2024.
PAVmed earned net income of $401.00K in fiscal 2025, a net margin of 564.8%.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $71.00K | −97.6% | $401.00K | 564.8% | −$5.63 | −$5.24M |
| FY2024ended Dec 31, 2024 | $3.00M | +20.0% | $39.79M | 1,326.4% | $14.90 | −$33.61M |
| FY2023ended Dec 31, 2023 | $2.50M | +563.1% | −$64.18M | −2,567.0% | −$9.16 | −$52.28M |
| FY2022ended Dec 31, 2022 | $377.00K | −24.6% | −$88.98M | −23,602.9% | −$15.03 | −$72.53M |
| FY2021ended Dec 31, 2021 | $500.00K | — | −$50.35M | −10,069.4% | −$0.65 | −$42.06M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $33.00K | −$5.38M | −$0.87 |
| Q1 FY2026ended Mar 31, 2026 | $22.00K | −$60.00K | −$4.42 |
| Q4 FY2025ended Dec 31, 2025 | $52.00K | −$1.26M | $6.64 |
| Q3 FY2025ended Sep 30, 2025 | $5.00K | −$5.38M | −$0.29 |
| Q2 FY2025ended Jun 30, 2025 | $6.00K | −$11.92M | −$22.08 |
| Q1 FY2025ended Mar 31, 2025 | $8.00K | $18.97M | $10.10 |
| Q4 FY2024ended Dec 31, 2024 | $0.00 | $1.43M | $17.27 |
| Q3 FY2024ended Sep 30, 2024 | $1.00M | $64.40M | $1.44 |
Company profile
- Name
- PAVmed Inc.
- Ticker
- PAVM
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- 360 Madison Avenue, 25th Floor, New York, NY 10017
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001624326
Recent SEC filings
- Sep 10, 2026
- Aug 14, 2026
- Aug 13, 2026
- Jun 24, 2026
- May 15, 2026
- May 14, 2026
- Mar 30, 2026
- Mar 27, 2026
Frequently asked questions
What is PAVmed's stock price?
PAVmed (PAVM) closed at $852.11 on Oct 9, 2026, down 1.40% from the previous close of $864.23.
What is PAVmed's market cap?
PAVmed's market cap is $5.34B, based on a share price of $852.11 and 6.3M shares outstanding as of Jun 30, 2026.
How much revenue does PAVmed make?
PAVmed reported revenue of $71.00K for fiscal 2025, down 97.63% from fiscal 2024.
What is PAVM's P/E ratio?
PAVmed's price-to-earnings ratio is 803.9, based on trailing twelve-month diluted EPS of $1.06.
Does PAVmed pay a dividend?
PAVmed's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from PAVmed Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures